SLAS2016 Scientific Program Committee
Conference Chairs
Doug Auld, Ph.D.
Novartis Institutes for Biomedical Research
Dino Di Carlo, Ph.D.
University of California, Los Angeles
Advances in Bioanalytics, Biomarkers and Diagnostics:
Track Chair:
Wilson Shou, Bristol-Myers Squibb
Wilson Shou, Bristol-Myers Squibb
Associate Track Chair:
Mary Savage, Merck
Mary Savage, Merck
Assay Development & Screening:
Track Chair:
J. Fraser Glickman, Rockefeller University
J. Fraser Glickman, Rockefeller University
Associate Track Chair:
Cathy Tralau-Stewart, University of California, San Francisco
Cathy Tralau-Stewart, University of California, San Francisco
Automation and High Throughput Technologies:
Track Chair:
Timothy Spicer, Scripps
Timothy Spicer, Scripps
Associate Track Chair:
Craig Schulz, Amgen
Craig Schulz, Amgen
Cellular Technologies:
Track Chair:
Andrea Weston, Bristol-Myers Squibb
Andrea Weston, Bristol-Myers Squibb
Associate Track Chair:
John Doench, Broad Institute
John Doench, Broad Institute
Drug Target Strategies:
Track Chair:
Michelle Arkin, University of California, San Francisco
Michelle Arkin, University of California, San Francisco
Associate Track Chair:
David Swinney, Institute for Rare and Neglected Diseases Drug Discovery
David Swinney, Institute for Rare and Neglected Diseases Drug Discovery
Informatics:
Track Chair:
Ellen Berg, Bioseek
Ellen Berg, Bioseek
Associate Track Chair:
Barry Bunin, Collaborative Drug Discovery
Barry Bunin, Collaborative Drug Discovery
Micro/Nano Technologies:
Track Chair:
Daniel Huh, University of Pennsylvania
Daniel Huh, University of Pennsylvania
Associate Track Chair:
Sindy Tang, Stanford University
Sindy Tang, Stanford University
